gafervit
bioveta -
ultravist 300 mg/ml raztopina za injiciranje
bayer d.o.o. - jod - raztopina za injiciranje - jod 300 mg / 1 ml - jopromid
ultravist 300 mg/ml raztopina za injiciranje
bayer d.o.o. - jod - raztopina za injiciranje - jod 300 mg / 1 ml - jopromid
ultravist 370 mg/ml raztopina za injiciranje
bayer d.o.o. - jod - raztopina za injiciranje - jod 370 mg / 1 ml - jopromid
ultravist 300 mg/ml raztopina za injiciranje
bayer d.o.o. - jod - raztopina za injiciranje - jod 300 mg / 1 ml - jopromid
ultravist 370 mg/ml raztopina za injiciranje
bayer d.o.o. - jod - raztopina za injiciranje - jod 370 mg / 1 ml - jopromid
ultravist 370 mg/ml raztopina za injiciranje
bayer d.o.o. - jod - raztopina za injiciranje - jod 370 mg / 1 ml - jopromid
nexpovio
stemline therapeutics b.v. - selinexor - multiple myeloma - antineoplastična sredstva - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.